GLAXO WELLCOME ULTIVA ANALGESIC OPIOID RAPID ONSET/OFFSET TIME IN GENERAL ANESTHESIA ACHIEVES EFFECT WITHOUT DELAYING PATIENT RECOVERY -- FDA CMTE.
Executive Summary
Glaxo Wellcome's Ultiva (remifentanil) is different from other opioid analgesics because its half-life of three to six minutes allows for a much more rapid onset/offset time, the company said during an April 29 presentation before FDA's Anesthetic & Life Support Advisory Committee, which recommended Ultiva for approval. Glaxo's NDA submission was filed in September 1995.